DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.
The firm said its test detects biomarkers inside monocyte blood cells that reflect the reduced clearance of amyloid-beta plaque that leads to Alzheimer's disease.
The firm said it is developing a rapid test for chlamydia and gonorrhea that will be able to detect multiple infections in the same sample in around 15 minutes.
The company said the study will evaluate the ability of its Reveal System to detect and characterize antimicrobial resistance of Gram-negative bacteremia samples.
